EN PL
Vaccinations in rheumatic diseases
 
More details
Hide details
1
Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Poland
 
2
Polish Society of Vaccinology
 
 
Online publication date: 2021-09-08
 
 
Reumatologia 2021;(Konferencja Pacjent post-COVID-owy. Co zostaje, a co się zmienia? 1):61-62
 
ABSTRACT
Vaccines are products of biological origin, which, by inducing immunity, prevent or alleviate infections and infectious diseases. The risk of infection is particularly high in patients with autoimmune inflammatory rheumatic diseases (AIIRD) because associated diseases and immunosuppressive therapies increase the contagious burden. The European League Against Rheumatism(EULAR) helps us in planning vaccinations for this group of patients, and at the end of 2019 updated their recommendations. EULAR addressed them to all doctors involved in the care of patients with AIIRD. The 2019 update for vaccination in adult patients with AIIRD is divided into six overarching principles and nine recommendations. According to the opinion of Polish experts, immunization in children with rheumatic diseases can follow the same recommendations [1].
 
REFERENCES (11)
1.
Jóźwiak H, Wysocki J. Szczepienia ochronne w profilaktyce chorób zakaźnych. Przewodnik Lekarza/Guide for GPs 2001; 4: 42-47.
 
2.
Furer V, Rondaan C, Heijstek MW, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2020; 79: 39-52, DOI: 10.1136/annrheumdis-2019-215882.
 
3.
Dirven L, Huizinga TWJ, Allaart CF. Risk factors for reported influenza and influenza-like symptoms in patients with rheumatoid arthritis. Scand J Rheumatol 2012; 41: 359-36, DOI: 10.3109/03009742.2012.670729.
 
4.
Shea KM, Edelsberg J, Weycker, et al. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis 2014;1: ofu024, DOI: 10.1093/ofid/ofu024.
 
5.
 
6.
Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 2015; 372: 2087-2896, DOI: 10.1056/NEJMoa1501184.
 
7.
Staples JE, Gershman M, Fischer M, et al. Yellow fever vaccine: recommendations of the Advisory Committee on immunization practices (ACIP). MMWR Recomm Rep 2010; 59: 1-27.
 
8.
Soybilgic A, Onel KB, Utset T, et al. Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years. Pediatr Rheumatol Online J 2013; 11: 29, DOI: 10.1186/1546-0096-11-29.
 
9.
Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58: 309-318, DOI: 10.1093/cid/cit816.
 
10.
Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016; 75: 795-810, DOI: 10.1136/annrheumdis-2015-208840.
 
11.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top